Lamivudine
Backbone antiretroviral also active against hepatitis B.
- Starts working
- Weeks
- Half-life
- 5–7 hours (intracellular 18–22 hours)
- In use since
- —
- Pregnancy
- Generally considered safe
Overview
Lamivudine is an NRTI that is part of most HIV regimens and is also used at a lower dose for hepatitis B. It is well tolerated but resistance develops quickly when used alone.
Conditions it's used for
How it works
Blocks HIV and hepatitis B viruses from copying themselves.
Lamivudine belongs to the Nucleos(t)ide reverse transcriptase inhibitors. How Nucleos(t)ide reverse transcriptase inhibitors work: act as faulty building blocks that stop the virus copying its genetic material into DNA.
Uses
- HIV infection (with other drugs)
- Chronic hepatitis B
Available as: tablet, oral solution, fixed-dose combinations.
Typical dose
- Adults
- 300 mg once a day or 150 mg twice a day for HIV; 100 mg once a day for hepatitis B.
- Children
- Weight-based dosing.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Headache
- Nausea
- Tiredness
- Cough
Serious — get medical help
Uncommon, but need prompt attention
- Hepatitis flare on stopping in co-infected people
- Lactic acidosis (rare)
- Pancreatitis in children
Warnings
- Never used alone for HIV
- Do not stop abruptly if hepatitis B co-infection
Who should avoid it
- Taking emtricitabine (same class)
Interactions
- Trimethoprim (co-trimoxazole) — raises lamivudine levels slightly
- Zalcitabine — avoid
- Sorbitol-containing medicines — lower levels
Using it safely
- Alcohol
- Best to limit. Alcohol adds to liver strain, particularly in hepatitis B.
- Food and drink
- With or without food.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Do not stop without advice, especially with hepatitis B.
- Driving
- No effect.
- Tests and checks
- HIV viral load; CD4 count; HBV markers; Kidney function
- If too much is taken
- Little toxicity; seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Generally considered safe
Widely used in pregnancy within HIV regimens.
Breastfeeding
Usually avoided
In high-income countries breastfeeding is not advised with HIV; where formula is unsafe, guidelines support breastfeeding with treatment.
Special groups
- Kidney disease
- Reduce dose if clearance below 50 mL/min.
- Liver disease
- Use caution with hepatitis flare risk.
- Older adults
- Dose by kidney function.
Brand names
- United States
- Epivir
- United Kingdom
- Epivir
- India
- Lamivir, Lamivudine (generic)
- Australia
- Zeffix, 3TC
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Lamivudine?
Yes — Lamivudine is prescription-only in most countries.
Can I take Lamivudine during pregnancy?
Generally considered safe. Widely used in pregnancy within HIV regimens. Always check with a doctor or midwife.
How quickly does Lamivudine work?
Weeks.
Related medicines
Tenofovir disoproxil
Backbone drug for HIV treatment, PrEP and hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsZidovudine
The first HIV drug, still used to prevent mother-to-child transmission.
RxWHONucleos(t)ide reverse transcriptase inhibitorsAbacavir
NRTI with a serious HLA-B*5701 hypersensitivity warning.
RxWHONucleos(t)ide reverse transcriptase inhibitorsDolutegravir
Core of the WHO-preferred HIV treatment.
RxWHOIntegrase inhibitorsEmtricitabine-tenofovir
Two-drug HIV backbone and daily HIV prevention pill (PrEP).
RxNucleos(t)ide reverse transcriptase inhibitorsEntecavir
First-line antiviral for chronic hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — J05AF05
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.